Mendeleev Commun., 2017, 27, 231–233
2 (a) S. M. Rida, S. A. M. El-Hawash, H. T. Y. Fahmy, A. A. Hazzaa and
This reaction, in conjunction with oxidative cyclization of
aldehydes 1 with aromatic diamines 2 in DMSO in the presence
of NH4Br, represents a convenient one-pot approach to the fused
isoquinolines from available starting compounds. Compared to
known procedures which require application of transition metal
catalysts, harsh conditions (lengthy heating at high temperatures)
or toxic solvents (like nitrobenzene), it is characterized by low
cost of reagents and simple experimental technique.
In summary, we have developed new one-pot transition metal-
free syntheses of 11-arylmethylidene-11H-isoindolo[2,1-a]benz-
imidazoles and 6-arylbenzimidazo[2,1-a]isoquinolines from
o-alkynylbenzaldehydes and o-diaminobenzenes in DMSO. An
important feature of this approach is opportunity to perform
5-exo-dig or 6-endo-dig ring closure at the final stage by simple
modification of reaction conditions.
M. M. M. El-Meligy, Arch. Pharmacal Res., 2006, 29, 826; (b) L. W.
Deady, T. Rodemann, G. J. Finlay, B. C. Baguley and W. A. Denny,
Anti-Cancer Drug Des., 2000, 15, 339; (c) V. K. Pandey and A. Shukla,
Indian J. Chem., Sect. B, 1999, 38, 1381; (d) Z. X. Lu, N. H. Quazi,
L. W. Deady and G. M. Polya, Biol. Chem. Hoppe-Seyler, 1996, 377,
373; (e) R. L. Weinkauf, A. Y. Chen, C. Yu, L. Liu, L. Barrows and
E. J. LaVoie, J. Bioorg. Med. Chem., 1994, 2, 781.
3 G. Dyker, W. Stirner and G. Henkel, Eur. J. Org. Chem., 2000, 1433.
4 N. Okamoto, K. Sakurai, M. Ishikura, K. Takeda and R. Yanada,
Tetrahedron Lett., 2009, 50, 4167.
5 H.-C. Ouyang, R.-Y. Tang, P. Zhong, X.-G. Zhang and J.-H. Li, J. Org.
Chem., 2011, 76, 223.
6 V. Rustagi, T. Aggarwal and A. K. Verma, Green Chem., 2011, 13, 1640.
7 J. Lu and H. Fu, J. Org. Chem., 2011, 76, 4600.
8 J. Lu, H. Zhang, X. Chen, H. Liu, Y. Jiang and H. Fu, Adv. Synth. Catal.,
2013, 355, 529.
9 (a) X. Z. Zhao, K. Maddali, C. Marchand, Y. Pommier and T. R. Burke,
J. Bioorg. Med. Chem., 2009, 17, 5318; (b) S. Pandey and R. S. Srivastava,
Lett. Drug Des. Discov., 2010, 7, 694; (c) P. Dydio, D. Lichosyt and
J. Jurczak, Chem. Soc. Rev., 2011, 40, 2971.
This work was supported by the Russian Foundation for Basic
Research (grant no. 15-03-08195 A).
10 S. Arulmurugan, H. P. Kavitha, S. Sathishkumar and R. Arulmozhi,
Mini-Rev. Org. Chem., 2015, 12, 178.
11 K. N. Shavrin, V. D. Gvozdev and O. M. Nefedov, Mendeleev Commun.,
2013, 23, 140.
12 V. D. Gvozdev, K. N. Shavrin and O. M. Nefedov, Russ. Chem. Bull.,
Int. Ed., 2013, 62, 2430 (Izv. Akad. Nauk, Ser. Khim., 2013, 2430).
13 V. D. Gvozdev, K. N. Shavrin, M. P. Egorov and O. M. Nefedov, Mendeleev
Commun., 2015, 25, 329.
14 V. D. Gvozdev, K. N. Shavrin and O. M. Nefedov, Russ. Chem. Bull.,
Int. Ed., 2014, 63, 409 (Izv. Akad. Nauk, Ser. Khim., 2014, 409).
15 V. D. Gvozdev, K. N. Shavrin, M. P. Egorov and O. M. Nefedov, Mendeleev
Commun., 2016, 26, 3.
Online Supplementary Materials
Supplementary data associated with this article can be found
in the online version at doi: 10.1016/j.mencom.2017.05.004.
References
1 (a) K. I. Takao, R. Munakata and K. I. Tadano, Chem. Rev., 2005, 105,
4779; (b) A. Mieczkowski, V. Roy and L. A. Agrofoglio, Chem. Rev.,
2010, 110, 1828.
6-Phenylbenzimidazo[2,1-a]isoquinoline 5a was prepared from aldehyde
1a and diamine 2a in 80% yield. 1H NMR, d: 6.49 (d, 1H, C8H, 3J 8.4 Hz),
6.88 (s, 1H, C5H), 7.00 (dd, 1H, C9H, 3J 8.4 Hz, 3J 7.7 Hz), 7.39 (dd, 1H,
C10H, 3J 8.2 Hz, 3J 7.7 Hz), 7.54–7.74 (m, 8H, C2H, C3H, C4H, Ph), 8.01
16 V. D. Gvozdev, K. N. Shavrin, E. G. Baskir, M. P. Egorov and O. M.
Nefedov, Russ. Chem. Bull., Int. Ed., 2016, 65, 1829 (Izv. Akad. Nauk,
Ser. Khim., 2016, 1829).
17 J. Peng, G. Shang, C. Chen, Z. Miao and B. Li, J. Org. Chem., 2013, 78,
1242.
3
(d, 1H, C11H, J 8.2 Hz), 8.85–8.95 (m, 1H, C1H). 13C NMR, d: 112.6,
114.1 (C5, C8), 119.5 (C11), 121.2, 124.2 (C9, C10), 122.7 (C12b), 125.0,
126.6, 127.8, 129.8, 130.1 (C1, C2, C3, C4; C4, Ph), 128.9, 129.3 (C2, C3,
C5, C6, Ph), 130.6, 131.5, 134.5 (C7a, C11a; C1, Ph), 137.4 (C6), 144.0
(C4a), 148.1 (C12a). HRMS, m/z 295.1226 [M+H]+ (calc. for C21H14N2,
m/z: 295.1231). These data are in good agreement with the reported ones.17
For characteristics of compounds 5b–e, see Online Supplementary
Materials.
Received: 7th October 2016; Com. 16/5067
– 233 –